Norbert Ndjeka

Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study

Kathryn Schnippel, Norbert Ndjeka, Gary Maartens et al. · The Lancet Respiratory Medicine · 2018 · 261 citations

Medicine, Infectious Diseases, Pharmacology +16

Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF

Gavin Churchyard, Wendy Stevens, L D Mametja et al. · The Lancet Global Health · 2015 · 218 citations · Full text

Public Health, Infectious Diseases, Internal Medicine +17

Tuberculosis control in South Africa: Successes, challenges and recommendations

Gavin Churchyard, L D Mametja, Lindiwe Mvusi et al. · South African Medical Journal · 2014 · 174 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +17

Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis

Norbert Ndjeka, Francesca Conradie, Kathryn Schnippel et al. · The International Journal of Tuberculosis and Lung Disease · 2015 · 137 citations

Public Health, Infectious Diseases, Pharmacology +17

High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen

Norbert Ndjeka, Kathryn Schnippel, Iqbal Master et al. · European Respiratory Journal · 2018 · 134 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17